These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 31525691)

  • 1. Engineered nano-immunopotentiators efficiently promote cancer immunotherapy for inhibiting and preventing lung metastasis of melanoma.
    Luo L; Iqbal MZ; Liu C; Xing J; Akakuru OU; Fang Q; Li Z; Dai Y; Li A; Guan Y; Wu A
    Biomaterials; 2019 Dec; 223():119464. PubMed ID: 31525691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engineered fluorescent carbon dots as promising immune adjuvants to efficiently enhance cancer immunotherapy.
    Luo L; Liu C; He T; Zeng L; Xing J; Xia Y; Pan Y; Gong C; Wu A
    Nanoscale; 2018 Nov; 10(46):22035-22043. PubMed ID: 30452049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced antitumor immunity by targeting dendritic cells with tumor cell lysate-loaded chitosan nanoparticles vaccine.
    Shi GN; Zhang CN; Xu R; Niu JF; Song HJ; Zhang XY; Wang WW; Wang YM; Li C; Wei XQ; Kong DL
    Biomaterials; 2017 Jan; 113():191-202. PubMed ID: 27816821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequential delivery of an anticancer drug and combined immunomodulatory nanoparticles for efficient chemoimmunotherapy.
    Heo MB; Kim SY; Yun WS; Lim YT
    Int J Nanomedicine; 2015; 10():5981-92. PubMed ID: 26451105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA-inorganic hybrid nanovaccine for cancer immunotherapy.
    Zhu G; Liu Y; Yang X; Kim YH; Zhang H; Jia R; Liao HS; Jin A; Lin J; Aronova M; Leapman R; Nie Z; Niu G; Chen X
    Nanoscale; 2016 Mar; 8(12):6684-92. PubMed ID: 26947116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted antigen delivery to dendritic cell via functionalized alginate nanoparticles for cancer immunotherapy.
    Zhang C; Shi G; Zhang J; Song H; Niu J; Shi S; Huang P; Wang Y; Wang W; Li C; Kong D
    J Control Release; 2017 Jun; 256():170-181. PubMed ID: 28414151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting dendritic cells with antigen-containing liposomes: a highly effective procedure for induction of antitumor immunity and for tumor immunotherapy.
    van Broekhoven CL; Parish CR; Demangel C; Britton WJ; Altin JG
    Cancer Res; 2004 Jun; 64(12):4357-65. PubMed ID: 15205352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dasatinib alters the metastatic phenotype of B16-OVA melanoma in vivo.
    Fraser CK; Lousberg EL; Guerin LR; Hughes TP; Brown MP; Diener KR; Hayball JD
    Cancer Biol Ther; 2010 Oct; 10(7):715-27. PubMed ID: 20676039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylactic immunization with Bubble liposomes and ultrasound-treated dendritic cells provided a four-fold decrease in the frequency of melanoma lung metastasis.
    Oda Y; Suzuki R; Otake S; Nishiie N; Hirata K; Koshima R; Nomura T; Utoguchi N; Kudo N; Tachibana K; Maruyama K
    J Control Release; 2012 Jun; 160(2):362-6. PubMed ID: 22192573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted Codelivery of an Antigen and Dual Agonists by Hybrid Nanoparticles for Enhanced Cancer Immunotherapy.
    Zhang L; Wu S; Qin Y; Fan F; Zhang Z; Huang C; Ji W; Lu L; Wang C; Sun H; Leng X; Kong D; Zhu D
    Nano Lett; 2019 Jul; 19(7):4237-4249. PubMed ID: 30868883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymer nanoparticles for enhanced immune response: combined delivery of tumor antigen and small interference RNA for immunosuppressive gene to dendritic cells.
    Heo MB; Cho MY; Lim YT
    Acta Biomater; 2014 May; 10(5):2169-76. PubMed ID: 24394635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous T Cell Activation and Macrophage Polarization to Promote Potent Tumor Suppression by Iron Oxide-Embedded Large-Pore Mesoporous Organosilica Core-Shell Nanospheres.
    Chen L; Ma X; Dang M; Dong H; Hu H; Su X; Liu W; Wang Q; Mou Y; Teng Z
    Adv Healthc Mater; 2019 May; 8(9):e1900039. PubMed ID: 30838801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prophylactic Dendritic Cell-Based Vaccines Efficiently Inhibit Metastases in Murine Metastatic Melanoma.
    Markov OV; Mironova NL; Sennikov SV; Vlassov VV; Zenkova MA
    PLoS One; 2015; 10(9):e0136911. PubMed ID: 26325576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The enhanced antitumor-specific immune response with mannose- and CpG-ODN-coated liposomes delivering TRP2 peptide.
    Lai C; Duan S; Ye F; Hou X; Li X; Zhao J; Yu X; Hu Z; Tang Z; Mo F; Yang X; Lu X
    Theranostics; 2018; 8(6):1723-1739. PubMed ID: 29556352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytomegalovirus-Based Vaccine Expressing a Modified Tumor Antigen Induces Potent Tumor-Specific CD8(+) T-cell Response and Protects Mice from Melanoma.
    Qiu Z; Huang H; Grenier JM; Perez OA; Smilowitz HM; Adler B; Khanna KM
    Cancer Immunol Res; 2015 May; 3(5):536-46. PubMed ID: 25633711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific peptide-mediated immunity against established melanoma tumors with dendritic cells requires IL-2 and fetal calf serum-free cell culture.
    Eggert AO; Becker JC; Ammon M; McLellan AD; Renner G; Merkel A; Bröcker EB; Kämpgen E
    Eur J Immunol; 2002 Jan; 32(1):122-7. PubMed ID: 11754352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The induction of maturation on dendritic cells by TiO2 and Fe(3)O(4)@TiO(2) nanoparticles via NF-κB signaling pathway.
    Zhu R; Zhu Y; Zhang M; Xiao Y; Du X; Liu H; Wang S
    Mater Sci Eng C Mater Biol Appl; 2014 Jun; 39():305-14. PubMed ID: 24863229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Protein and Peptide Targeting for the Development of a CD169-Based Vaccination Strategy Against Melanoma.
    van Dinther D; Veninga H; Revet M; Hoogterp L; Olesek K; Grabowska J; Borg EGF; Kalay H; van Kooyk Y; den Haan JMM
    Front Immunol; 2018; 9():1997. PubMed ID: 30237798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small EV-based delivery of CpG ODNs for melanoma postsurgical immunotherapy.
    Lu Y; Ye H; Zhao J; Wang K; Fan X; Lu Q; Cao L; Wan B; Liu F; Sun F; Chen X; He Z; Liu H; Sun J
    J Control Release; 2023 Nov; 363():484-495. PubMed ID: 37778468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Making It Personal: Neoantigen Vaccines in Metastatic Melanoma.
    Hellmann MD; Snyder A
    Immunity; 2017 Aug; 47(2):221-223. PubMed ID: 28813655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.